| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.200 | None | 0.977 | 1053 | 8 | 1998 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.984 | 639 | 3 | 1999 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.200 | None | 0.967 | 424 | 26 | 1991 | 2020 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.200 | None | 0.940 | 336 | 10 | 1989 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.982 | 334 | 2 | 2003 | 2020 | ||||||||
|
neurofibromin 2 | 0.468 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.965 | 227 | 2 | 1992 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.991 | 213 | 1 | 2000 | 2020 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.976 | 207 | 0 | 1999 | 2020 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.964 | 192 | 1 | 1991 | 2020 | ||||||||
|
patched 1 | 0.398 | 0.885 | 1.00 |
|
group | 0.200 | None | 0.971 | 174 | 0 | 1989 | 2019 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.950 | 161 | 9 | 1994 | 2019 | ||||||||
|
aminopeptidase puromycin sensitive | 0.519 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.929 | 156 | 0 | 1994 | 2020 | ||||||||
|
TSC complex subunit 2 | 0.439 | 0.808 | 1.00 |
|
group | 0.200 | None | 0.971 | 139 | 4 | 1990 | 2020 | ||||||||
|
DNA methyltransferase 1 | 0.406 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.992 | 124 | 0 | 2000 | 2020 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
group | 0.100 | None | 0.958 | 118 | 0 | 2001 | 2020 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
group | 0.200 | None | 0.972 | 108 | 5 | 1988 | 2019 | ||||||||
|
TSC complex subunit 1 | 0.440 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.969 | 96 | 0 | 1990 | 2019 | ||||||||
|
dicer 1, ribonuclease III | 0.446 | 0.846 | 1.00 |
|
group | 0.100 | None | 1.000 | 93 | 0 | 2002 | 2020 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.450 | 0.885 | 1.00 |
|
group | 0.100 | None | 1.000 | 92 | 0 | 1994 | 2020 | ||||||||
|
fms related receptor tyrosine kinase 4 | 0.457 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.950 | 80 | 0 | 1999 | 2019 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
group | 0.400 | None | 1.000 | 75 | 0 | 1999 | 2020 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 | 0.504 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 63 | 0 | 2002 | 2019 | ||||||||
|
jagged canonical Notch ligand 1 | 0.429 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.984 | 62 | 0 | 1998 | 2020 | ||||||||
|
TEK receptor tyrosine kinase | 0.462 | 0.692 | 1.00 |
|
group | 0.100 | None | 1.000 | 61 | 0 | 1998 | 2019 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.914 | 58 | 1 | 1991 | 2020 |